Fc Fusion Protein Market Size to Reach USD 59.48 Billion in 2028 Growing at a CAGR of 10.5%, According to Latest Analysis by Emergen Research
Emergen Research has published its latest report titled “Fc Fusion Protein Market, By Type (Biosimilar Drugs, Brands Drugs), By Therapeutic Area (Eye Diseases, Hemophilia, Autoimmune Disease, Diabetes, Others), By Application (In Vitro, In Vivo), By End-use (Hospitals, Ophthalmic Hospitals, Oculoplastic Clinics), and By Region, Forecast to 2028”
According to Emergen Research, the global Fc fusion protein market size was USD 26.97 billion in 2020 and is expected to reach USD 59.48 billion in 2028 and register a revenue CAGR of 10.5% during the forecast period, 2021-2028.
The global Fc fusion protein market revenue growth is majorly supported by factors such as growing use in-vivo and in-vitro R&D activities and drug development, rapid spread of infectious diseases including the COVID-19, and increasing use of Fc fusion protein in development of COVID-19 vaccines. Fc fusion protein, also referred to as Fc chimeric fusion protein or Fc-tag protein, is widely used in in-vivo and in-vitro studies, and the commonly known Fc-fused binding partners include single peptides, signaling molecules, ligands activated by cell-surface receptor interaction, extracellular domains of receptors, and bait proteins used in protein microarrays. Increasing prevalence of diabetes worldwide, growing use of Fc fusion protein in development of diabetes medications and therapeutic agents, and increasing non-clinical applications of Fc fusion proteins including immunohistochemistry, flow cytometry, and protein microarrays are other major factors expected to bolster the global market revenue growth over the forecast period.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/816
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Diabetes Segment Accounted for Largest Revenue Share in 2020:
Based on therapeutic area, the global Fc fusion protein market is segmented into eye diseases, hemophilia, autoimmune disease, diabetes, and others. The diabetes segment dominated other therapeutic area segments in terms of revenue share in 2020, owing to favorable factors such as increasing geriatric population, rising prevalence of diabetes across the globe, growing use of Fc fusion protein in formulating diabetes medications, and increasing investments in R&D programs for advanced diabetes therapeutics.
In vitro Application Segment to Account for Fastest Revenue CAGR:
Based on application, the global Fc fusion protein market is primarily segmented into in vitro and in vivo. The in vitro segment is sub-segmented into immunohistochemistry, flow cytometry, binding assays, and microarray technologies. The in vitro segment is expected to register fastest revenue growth rate in the global market over the forecast period owing to factors such as increasing applications of Fc fusion protein in binding assays, immunohistochemistry, flow cytometry, and microarray technologies.
Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/816
North America Accounted for Largest Revenue Share in 2019:
Among regional markets, the North America Fc fusion protein market accounted for the largest revenue share in the global market in 2020. Major factors driving the regional market revenue growth include increasing prevalence of diabetes, eye diseases, and autoimmune disorders, growing use of advanced Fc-fusion proteins in drug and vaccine development, rising cases of COVID-19, and rapidly growing demand for COVID-19 vaccines. Rise in geriatric population, rising awareness of the advantages of Fc fusion protein-based medications, growing demand for Fc fusion protein-derived bio-therapeutic drugs, and presence of key players in the region, such as Pfizer Inc., Regeneron Pharmaceuticals, Inc., Bristol-Myers Squibb Company, and Eli, Lilly and Company, further bolster the North America market revenue growth.
Major Companies in the Global Fc Fusion Protein Market Include:
- Sanofi S.A.
- Bristol-Myers Squibb Company
- Amgen Inc.
- Pfizer Inc.
- Swedish Orphan Biovitrum AB
- Eli, Lilly and Company
- Astellas Pharma Inc.
- Bayer AG
- Regeneron Pharmaceuticals, Inc.
- 3SBio Inc.
For the purpose of this report, Emergen Research has segmented the global Fc fusion protein market based on type, therapeutic area, application, end-use, and region:
Type Outlook (Revenue, USD Billion; 2018–2028)
- Biosimilar Drugs
- Brands Drugs
Therapeutic Area Outlook (Revenue, USD Billion; 2018–2028)
- Eye Diseases
- Autoimmune Disease
Application Outlook (Revenue, USD Billion; 2018–2028)
- In Vitro
- Flow Cytometry
- Binding Assays
- Microarray Technologies
- In Vivo
- Bio-therapeutic Drugs
End-use Outlook (Revenue, USD Billion; 2018–2028)
- Ophthalmic Hospitals
- Oculoplastic Clinics
Region Outlook (Revenue, USD Billion; 2018-2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Compound Management Market By Solution (Products and Outsourcing Services), By Sample Type (Chemical Compounds, Biosamples), By Application (Drug Discovery, Gene Synthesis, Biobanking, Others), By End-Use (Biopharma Companies, Pharma Companies, Biobank, CRO) and By Region Forecast to 2028
Antibody Services Market By Service (Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling), By Type (Monoclonal, Polyclonal), By End-Use (Bioscience Companies, Bioscience Research Institutions, Hospitals, Others), and By Regions Forecast to 2028
Organs-on-Chips Market By Type (Liver-on-Chip, Multiple Organs-on-Chips, Kidney-on-Chip, Heart-on-Chip, Lung-on-Chip, Intestine-on-Chip), By Application (Drug Discovery, Physiological Model Development, Toxicology Research), By End-Use (Pharmaceutical Firms, Research Institutes, Personal Care Industry), and By Region Forecast to 2028
RNA Transcriptomics Market By Product (Reagents, Instruments, Software, Service), By Technology (Microarrays, Polymerase Chain Reaction, RNA Sequencing, RNA Interference), By Application (Clinical Diagnostics, Toxicogenomics, Drug Discovery, Comparative Transcriptomics), By End-Use (Hospitals, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations). and By Region
Slide Stainers Market By Product (Reagents, Consumables & Accessories, Equipment), By Technology (Hematoxylin and Eosin, Immunohistochemistry, In Situ Hybridization, Cytology, Microbiology, Hematology, Special Stains), By End-Use (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Other), and By Region Forecast to 2028
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-fc-fusion-protein-market